Awards and Honors, Business, Drugs and Pharmaceuticals, e-Commerce, Free News Articles, Long Term Care, Software

Healthcare Tech Outlook Names Delta Care Rx a Top 10 Pharmacy Management Solution Provider

FREMONT, Calif. -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, has been named one of the "Top 10 Pharmacy Management Solution Providers of 2018," according to Healthcare Tech Outlook, a digital and print magazine publication of Valley Media, Inc.

The "Top 10" award was published online March 27, as well as in a Special Issue print edition on April 5, with Delta Care Rx Founder, President, and COO Drew Mihalyo on its cover. Mihalyo, known for his commitment to technological innovation providing unique programs for hospice customers exclusively offered by Delta Care Rx, is quick to share the credit for the company's success.

"This recognition is a testament to the strength and commitment of the entire Delta Care Rx team," says Mihalyo. "We work together, both within Delta and with our integration partners, to ensure prompt attention and great sensitivity to meet each patient's needs related to pain and symptom management."

The in-depth feature article, "Delta Care Rx: Enhancing the End of Life Care Experience," states that the company "sets the industry benchmark in pharmaceutical benefits management in end of life care," fulfilling its mission of transparency and commitment to quality of care at every level of the organization. In addition to providing benefit management or mail order pharmacy to clients, Delta Care Rx offers a range of cutting edge telemedicine solutions designed to simplify workflow and ordering processes and improve quality of care. The article places these within the context of the broader pharmaceutical and end of life care industries.

"We take pride in honoring Delta Care Rx for offering innovative solutions that are revolutionizing the way hospice and palliative care providers are served in the Pharmacy Management arena," said Alex D'Souza, managing editor of Healthcare Tech Outlook.

With the announcement, Delta Care Rx joins an elite group of pharmacy management solutions providers known to provide innovative technologies which ultimately enhance clinical efficiency and dramatically reduce costs for hospice organizations. The magazine's editorial board independently applied a set of criteria to a broad selection of pharmacy management firms, then narrowed the designation to the Top 10 listing.

Delta Care Rx - http://www.deltacarerx.com/ - transforms and improves the hospice pharmacy industry through business transparency, innovation, extreme customer service, and the maintenance of vital community pharmacy relationships.

About Delta Care Rx:

As a pharmacist owned, privately held provider, Delta Care Rx - http://www.deltacarerx.com - sets the industry benchmark for pharmacy benefit management, creative prescription mail order, on-demand pharmacist services, and hospice tailored e-Prescribing. Additionally, Delta Care Rx offers electronic tools, including cutting-edge telemedicine technology, to improve the quality of palliative patient care during serious illness or at end of life and simplifies essential workflow/ordering processes within hospice settings.

About Healthcare Tech Outlook:

Published from Fremont, California, Healthcare Tech Outlook is a print magazine, which features CIOs, ITVPs, CTOs, and other decision makers sharing their insights and perspective on healthcare industry. A panel of experts, technology leaders and board members of Healthcare Tech Outlook magazine has finalized the "Top 10 Pharmacy Management Solution Providers 2018" and shortlisted the best vendors and consultants in the healthcare industry. For more info, visit: https://www.healthcaretechoutlook.com/.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Long Term Care, Product Launches, Software

Adapt by Delta Care Rx Debuts a Shared Patient-Clinician Palliative Care Experience Powered by TapCloud

PITTSBURGH, Pa. -- The simple touch of a finger sparks the newest innovation in the quest for quality, responsive patient-centered care. Adapt by Delta Care Rx, an advanced disease management and therapeutics solution, debuts a patient-clinician communication interface powered by TapCloud, a leading provider of real time patient generated health data.

Using a provided application, patients with serious, life altering illness will communicate symptoms and experiences directly to their care providers in real time.

"Clinicians using the Adapt dashboard will now enjoy unprecedented ability to maximize the benefits of care to the patient while enhancing efficiency and lowering costs," says Drew Mihalyo, founder, president and COO of Delta Care Rx. "The Adapt solution powered by TapCloud supports the 'triple aim' objective to which palliative care providers aspire."

Too, the partnership marks the first time that the pharmacist is fully integrated into patient-centered palliative care team conversations, say experts. Now, pharmacists can work side by side with colleagues across the care continuum, ensuring each patient's optimum quality of life.

"The entire team is aided by a dramatic increase of patient information available to them," says Mihalyo.

In less than one minute per day, patients can access the secure Adapt application from any internet connected digital device, including smart phones and tablets. With a simple touch of a finger, the patient chooses from a range of words selected specifically for his or her diagnosis and medications to report current symptoms or feelings in natural language, not medical terminology.

"We offer each person easy access to their professional caregivers, as well as the ability to share information in ways that are clinically relevant and easy to use," says Tom Riley, CEO of TapCloud and the platform's creator.

Conversely, clinicians and pharmacists who make up the care team will be able to quickly assess whether a patient feels better or worse, gauge the effectiveness of medication or treatments, check vital signs, or identify the onset of complications.

"Previously, the patient and family's ability to recognize, remember, and report key information about what happens between clinical visits has been limited," says Riley. "Now we are able, with the use of one simple tool, to amplify the voice of the patient and bring it to the front and center of care."

Clinicians using Adapt by Delta Care Rx will now see the TapCloud dashboards within the secure portal. Visual depictions of the data reported by each patient makes it possible to rapidly interpret key insights, assess well-being, spot developing complications or determine medication side-effects. Established protocols will dictate whether a patient needs to be seen, requires a home health visit, or needs a medication adjustment.

As a member of the palliative care team, the Delta Care Rx pharmacist provides 24 hour on-call services seven days per week. Within the scope of the clinical conversation, the pharmacist will be able to make notes for care team nurses and physicians that include medication alternatives, questions, or guidance tailored for each patient.

"Bringing pharmacist expertise into the team's discussion offers a significant enhancement to care," Mihalyo says. "With this model, we have the ability to see the total picture of patient care."

Delta Care Rx is a leading sponsor for the annual American Association of Hospice and Palliative Medicine, or AAHPM, Conference, April 14-16, in Boston, Mass. Attendees will network with peers in hospice and palliative care organizations from across the nation, while simultaneously learning from a broad variety of industry experts and thought leaders. Delta Care Rx President and COO Drew Mihalyo, PharmD, will be featured in a Showcase Theater, titled "What Telemedicine Can Do for YOUR Organization," with TapCloud's Tom Riley, CEO, on Friday, March 16.

Delta Care Rx partners with telemedicine innovators like TapCloud, to provide its clients with easy to use, innovative interfaces. These include Adapt by Delta Care Rx and powered by TapCloud, as well as HIPAA compliant, secure video conferencing and virtual patient engagement.

About Delta Care Rx:

Delta Care Rx - http://www.deltacarerx.com - transforms and improves the hospice pharmacy industry through business transparency, innovation, extreme customer service, and the maintenance of vital community pharmacy relationships. As a pharmacist owned, privately held provider, Delta Care Rx sets the industry benchmark for pharmacy benefit management, creative prescription mail order, on-demand pharmacist services, and hospice tailored e-Prescribing. Additionally, Delta Care Rx offers electronic tools, including cutting-edge telemedicine technology to improve the quality of palliative patient care during serious illness or at end of life, and simplifies essential workflow/ordering processes within hospice settings.

About Tap Cloud:

TapCloud - http://www.tapcloud.com/ - allows patients and providers to communicate in ways that improve the doctor-patient relationship, focus clinicians on patients that need the most attention, and ensure that the patients who require services receive those in a timely manner that maximizes health benefits, improves quality of life, and minimizes expenditures of health resources.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Long Term Care, Software

Delta Care Rx Now Interfaces with HEALTHCAREfirst Electronic Health Records

PITTSBURGH, Pa. -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces an exciting interface with HEALTHCAREfirst, a leading provider of web-based home health and hospice software, billing and coding services, Consumer Assessment of Healthcare Providers and Systems, or CAHPS, Surveys and advanced analytics.

The partnership enables Delta Care Rx Hospice pharmacy solutions to interface effortlessly with the HEALTHCAREfirst comprehensive electronic health records, or EHR, systems, including firstHOSPICE and firstHOMECARE.

"Delta Care Rx enjoys a growing segment of users within our customer base," says J. Kevin Porter, CEO of HEALTHCAREfirst, citing a recent, internal survey of clients. "This partnership strategically provides the interface those hospice clients need to create greater ease in workflow."

Thanks to the interface, slated for early April, clinicians will be able to enhance workflow efficiency from a single point of demographic data entry in the EHR, which will then flow electronically to Delta Care Rx.

For example, when a nurse inputs patient information into the HEALTHCAREfirst EHR, it appears in Delta Care Rx's e-tools automatically. The automatic transfer of vital information saves valuable time, reduces error, and improves patient care by reducing the effort required to ensure patients receive medications needed for quality outcomes.

In the future, a pharmaceutical interface will make it possible to order medications directly from the EHR. Users will also have the option of utilizing Delta Care Rx's user-friendly durable medical equipment (DME) management software and provider network. Again, as patient demographic information proves readily available in the e-tools software suite, there's no task repetition. Delta Care Rx pharmacy and DME orders can be placed from any digital device, including smart phones. There is no additional cost to HEALTHCAREfirst users who choose to add this interface.

"Managing pharmacy, alongside DME inside the same platform, definitely saves time and capital," says Drew Mihalyo, president and COO at Delta Care Rx. "This interface saves duplication of labor across the board for clients who already use a very powerful product via HEALTHCAREfirst."

Delta Care Rx partners with EHR vendors, like HEALTHCAREfirst, within the hospice industry to provide EHR clients with easy to use, innovative interfaces to enhance clinical efficiency and reduce operating costs.

About Delta Care Rx:

Delta Care Rx - http://www.deltacarerx.com - transforms and improves the hospice pharmacy industry through business transparency, innovation, extreme customer service, and the maintenance of vital community pharmacy relationships. As a pharmacist owned, privately held provider, Delta Care Rx sets the industry benchmark for pharmacy benefit management, creative prescription mail order, on-demand pharmacist services, and hospice tailored e-Prescribing. Additionally, Delta Care Rx offers electronic tools, including cutting-edge telemedicine technology to improve the quality of palliative patient care during serious illness or at end of life, and simplifies essential workflow/ordering processes within hospice settings.

About HEALTHCAREfirst:

HEALTHCAREfirst - http://www.healthcarefirst.com/ - provides web-based technologies and services to improve business and clinical operations for over four thousand home health and hospice providers across the United States. Based in Springfield, MO, and one of the fastest growing providers of its kind, the company provides, in any combination, agency and clinical management software; outsourced revenue cycle management services including billing, coding and home health Outcome and Assessment Information Set, or OASIS, Review; CAHPS surveys; and advanced analytics. HEALTHCAREfirst's breadth of solutions offers agencies a single source to improve patient care, create operational efficiencies, increase profitability and simplify CMS compliance. With HEALTHCAREfirst, agencies can focus on patients instead of paperwork.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Drugs and Pharmaceuticals, Free News Articles, Software

Delta Care Rx Now Integrates with Suncoast Electronic Medical Records

PITTSBURGH, Pa. -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces a robust integration with Suncoast by Complia Health, a leading global provider of home health care and hospice software solutions.

The Delta Care Rx hospice pharmacy benefits management (PBM) solution joins a growing list of other vendors which integrate effortlessly with the Suncoast industry standard electronic medical records (EMR) system. Now, clients with the Suncoast EMR are able to enhance efficiencies with a single point of data entry which will then flow electronically to Delta Care Rx.

"The integration allows an increased number of our clients to use the additional functionality of the software," says Nate Truitt, general manager of Suncoast by Complia Health. "We want to make certain our clients have access to all the software options available to them."

The integration:
* increases efficiency, saving time and costs
* eliminates redundancy of any data entry
* improves the quality of patient care
* provides a single point of entry for patient demographics and medication orders
* complements Delta Care Rx's proprietary and easy-to-use e-Tools suite of software.

The integration is inclusive of industry tailored e-Prescribing and durable medical equipment (DME) order management that works on any digital device, including smart phones.

A leading PBM, Delta Care Rx partners with top EMR vendors - like Suncoast by Complia - to provide innovative integration solutions which ultimately enhance clinical efficiency and dramatically reduce costs for hospice organizations.

According to David Clapp, national director of business development at Delta Care Rx, "We appreciate the opportunity to partner with quality providers like Suncoast by Complia. Together, we make it possible for our mutual clients to ensure patient quality of care across the care continuum."

Delta Care Rx is a leading sponsor for the second annual Complia Health CARE User Conference, Monday, Feb. 19, through Friday, Feb. 23, 2018 at the Marriott Orlando World Center, Orlando, Florida.

Attendees will network with peers in post-acute, home health, hospice and palliative care organizations, while simultaneously learning from a broad variety of industry experts and thought leaders, such as Delta Care Rx COO Drew Mihalyo, who will be featured in Thursday's Partner Showcase.

About Delta Care Rx:
Delta Care Rx - http://www.deltacarerx.com - transforms and improves the hospice pharmacy industry through business transparency, innovation, extreme customer service, and the maintenance of vital community-pharmacy relationships. As a pharmacist owned, privately held provider, Delta Care Rx sets the industry benchmark for pharmacy benefit management, mail order pharmacy options, on-demand pharmacist services, and hospice tailored electronic prescribing. Additionally, Delta Care Rx offers electronic tools, including cutting edge telemedicine technology, to improve the quality of patient care and simplify essential workflow and ordering processes within hospice settings.

About Complia Health:
Complia Health is a leading global provider of technology and expertise for the long-term and post-acute care market. Nearly 3,000 home health, residential, community care, and hospice organizations count on Complia Health for the clinical, operational, and financial solutions required to profitability deliver quality care. Complia Health's innovative products-including Procura, ContinuLink, Suncoast, Igea, and Progresa-are supported by a team of global health and technology experts located in the United States, Canada, and Australia. For more information, visit http://www.compliahealth.com/.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Awards and Honors, Drugs and Pharmaceuticals, Free News Articles

Delta Care Rx Announces Patrick White, MD, Inaugural Recipient of Delta Distinguished Scholar Award

PITTSBURGH, Pa. -- Delta Care Rx today announced the first-ever recipient of the Delta Distinguished Scholar award. Patrick White, MD, HMDC, FACP, FAAHPM, chief medical officer of BJC Hospice, St. Louis, http://www.bjchospice.org/, and assistant professor of medicine at Washington University, has received an initial $25,000 research grant, with a $500,000 lifetime potential, for study into the comparative and cost effectiveness of pharmaceuticals.

"Even if we can't cure, there are ways to relieve symptoms," says White, whose choice of hospice medicine was influenced by his experience at age 7, when he visited patients with cystic fibrosis with his father, a pulmonologist.

"Improving a cough or alleviating shortness of breath meant the world to those patients and their families," he says. "Now, through the research initiated by this grant, my team and I have a tremendous opportunity to reduce suffering and identify those most likely to benefit from particular drug therapies at end of life."

Delta Care Rx, www.deltacarerx.com, is a leading pharmaceutical innovator in the field of hospice medicine, offering its clients unparalleled transparency in the effectiveness and cost of medications. With an average of 1.5 million patients receiving hospice care annually in the U.S., the potential impact of White's research on symptom management and pain control has widespread implications.

White is distinguished by his "commitment to take hospice and palliative medicine to a higher level of extreme, patient-focused care," according to Delta Care Rx CEO Mary Mihalyo, PharmD, BCPS, CDE.

Mihalyo is a widely respected pioneer in the specialty of hospice pharmacy.

"In hospice and palliative medicine, there is a lack of evidence identifying the true pharmaco-economic nature of medications we use daily," says Mihalyo. "The hospice profession needs physicians who are also researchers."

To date, pharmaceutical research in hospice medicine is limited. Hospice patients are excluded from most clinical trials. This exclusion makes it difficult to determine which drug therapies are effective for hospice patients, and which are not. Too often, hospice clinicians must make choices based on affordability, not on efficacy.

"Some commonly prescribed medications actually reduce quality of life for hospice patients and offer no benefit toward survival," White says.

The award announcement follows closely that of last week's selection of White to serve on the Missouri Governor's interdisciplinary council on palliative care and quality of life. He currently serves as chair of the palliative care committee of the Missouri Hospice and Palliative Care Association, and sits the national Hospice Medical Director's Leadership Council of the American Academy of Hospice and Palliative Medicine.

"Patrick White exemplifies the physician-researcher model and has a demonstrated interest in cost effective medication use," says Mihalyo.

In hospice settings, clinicians need the ability to distinguish between medications that are believed to work but may not, and those which actually work, but may be underutilized. The specific medications studied under the auspices of the grant remain undisclosed.

"A talented researcher like Patrick White may be able to prove that newer medications are equally cost effective to those used historically," she says. "That would be very valuable information."

Through professional practice, White has experienced firsthand the costs associated with a lack of evidence for pharmaceutical use. Also, he offers demonstrated ability to build collegial relationships across the continuum of care to conduct the research needed.

"Identifying evidence through research allows those of us within the profession to develop patient-specific ways to identify the most appropriate intervention - which is not always the least expensive medication on the market," says Mihalyo.

The Delta Distinguished Scholars Program selects leading physician-researchers with expertise in hospice medicine for career development funding to offset direct research costs. Preference is given to early career investigators, like White, who have the potential to significantly impact the field.

"I am especially grateful this award came from Delta Care Rx," says White. "They are an integral part of the effort to advance the cause of quality patient-centered care."

The Delta Care Rx Hospice Taper(c) transparent and pass-through drug purchasing model should be the "gold standard," he says. The model assures that the amount a hospice pays for medication is always equal to the amount the dispensing pharmacist is reimbursed for filling an order.

In contrast, many hospice pharmacy benefit managers charge the hospice one amount then reimburse the dispensing pharmacist at a much lesser amount. The result is higher daily costs of care.

White hopes his team's research "will result in improved patient outcomes with a lower cost of care per day."

"When hospices are able to afford medications they couldn't previously because of price, patients get the interventions they deserve," says Drew Mihalyo, PharmD, Delta Care Rx founder, president, and COO. "As Dr. White considered the concept of enhanced access to medications, it set the framework for future research, which Delta Care embraced."

The Delta Scholar Award is by invitation only and will not occur annually. Successful applicants demonstrate a strong research background in comparative effectiveness or cost effectiveness research, outstanding leadership skills, and a proven commitment to advancing the field of hospice research. Physician-researchers may request an invitation to apply at http://www.deltacarerx.com/delta-campus/research.

About Delta Care:

Delta Care, http://www.deltacarerx.com, transforms and improves the hospice pharmacy industry through business transparency, innovation, extreme customer service, and the maintenance of vital community-pharmacy relationships. As a pharmacist owned, privately held provider, Delta Care sets the industry benchmark for pharmacy benefit management, on-demand pharmacist services, and hospice tailored electronic prescribing. Additionally, Delta Care offers tools and technologies to simplify essential workflow and ordering processes within hospice settings.

*PHOTO for media: Send2Press.com/mediaboom/17-0418s2p-Patrick-White-300dpi.jpg
*LOGO: Send2Press.com/mediaboom/17-0418s2p-delta-care-300dpi.jpg

This news story was published by the Neotrope® News Network - all rights reserved.